Danaher Corporation (LON:0R2B)
223.18
+12.82 (6.10%)
At close: Oct 21, 2025
Danaher Revenue
Danaher had revenue of $6.05B USD in the quarter ending September 26, 2025, with 4.40% growth. This brings the company's revenue in the last twelve months to $24.27B, up 2.22% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$24.27B
Revenue Growth
+2.22%
P/S Ratio
6.44
Revenue / Employee
$385.21K
Employees
63,000
Market Cap
116.56B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Danaher News
- 1 day ago - Examining the Future: Danaher's Earnings Outlook - Benzinga
- 1 day ago - Validea Detailed Fundamental Analysis - DHR - Nasdaq
- 3 days ago - DHR Quantitative Stock Analysis - Nasdaq
- 4 days ago - Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? - Nasdaq
- 5 days ago - Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR - GlobeNewsWire
- 5 days ago - Guru Fundamental Report for DHR - Nasdaq
- 6 days ago - Danaher Stock: Monopoly Margins, Discounted Price - Forbes
- 7 days ago - Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR - PRNewsWire